1Kontopoulou T , Tsaousis G , Vaidakis E , et al. hemophagocytic syndrome in association with visceral leishmaniasis[J]. Am J Med, 2002,113(5) :439-440.
2Endo R,Kikuta H. Possoble involvement in oncogenesis of a single base mutation in an internal ribosome entry site of Epstein-Barr nuclear antigen I Mrna[J]. J Med Virol,2004,72(4):630-634.
3Chuang HC , Lay JD , Hsieh WC , et al . Epstein Barr virus LMPlinhibits the expression of SAPgene and upregulatesThl cytokines in the pathogenesis of hemophagocytic syndrome [J]. Blood,2005,106(9) :3090-3096.
5Stabile A, Bertoni B, Ansuini V, et al. The clinical spectrum and treatment options of maeropbage activation syndrome in the pediatric age[J]. Eur Rev Med Pharmacol Sci,2006,10(2):53-59.
6Kounami S , Yoshiyama M , Nakayama K , et al . Macrophage activation syndromen chiIdren with systemic-onset juvenile chronic arthritis[J].Acta Haematol,2005,113(2) : 124-129.
7Villanueva J , Lee S , Giannini EH , et al . Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome [J].Arthritis Res Ther, 2005,7 (1) : 30-37.
8Imashuku S . Advances in the management of hemophagocytic Lymphohistiocytosis[J]. int J Hematol, 2000,72 : 1-11.
1Kosseian-Bal I, Bocquet H, Beneton N, et al. Hypersensitivitysyndrome during mycoplasma pneumoniae infection[J]. Ann DermatolVenercol, 1998,125(5):328-330.
2Reichert S, Barbaud A, Antunes A, et al. An unusual form of StevensJohnson syndrome with subcomeal pustules associated with mycoplasmapneumoniae infection[J]. Pediatr Dermatol, 2000,17(3):202- 204.
3Schamberger MS, Goel J, Braddock SR, et al. Stevens-Johnsonsyndrome and respiratory failure in a 9-year-old boy[J]. South MedJ, 1997,90(7):755-757.
4Murphy MI, Brant WE. Hematocolpos caused by genital bullouslesions in a patient with Stevens-Johnson syndrome[J]. J ClinUltrasound, 1998,26(1):52- 54.
5John T, Foulks GN, John ME, et al. Amniotic membrane in thesurgical management of acute toxic epidermal necrolysis[J]. Ophthalmo-logy, 2002,109(2):351 - 360.
6Goebels N, Helmchen C, Abele-Horn M, et al. Extensive myelitisassociated with mycoplasma pneumoniae infection: magnetic resonanceimaging and clinical long-term follow-up[J]. J Neurol, 2001,248(3):204- 208.
7Smith R, Eviater L. Neurologic manifestations of mycoplasmapneumoniae infections: diverse spectrum of diseases. A report of sixcases and review of the literature[J]. Clin Pediatr, 2000,39(4):195-201.
8Koskiniemi M. CNS manifestations associated with mycoplasmapneumoniae infections: summary of cases at the University of Helsinkiand review[J]. Clin Infect Dis, 1993,17(Suppl 1):S52-57.
9Clhergui K, Fourm T, Veillard-Baron A, et al. Mycoplasmapneumoniae and second-degree heart block[J]. Clin Infect Dis, 1998,27(6):1534-1535.
10Mizukane R, Kadota JI, Yamaguchi T, et al. An elderly patient withhemophagocytic syndrome due to severe mycoplasma pneumoniae withmarked hypercytokinemia[J]. Respiration, 2002,69(1):87-91.
